The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 335:59-61 July 4, 1996 Number 1
NextNext

Preinfarction Angina

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Andreotti, F.
-PubMed Citation
To the Editor: Before medical professionals consider changing their practice of administering thrombolytic agents on the basis of the presence or absence of preinfarction angina, as is suggested by Andreotti et al. (Jan. 4 issue),1 we feel obligated to comment on their study and present more recent data disputing their findings. The study involved a small number of patients (23) treated between 1987 and 1989 and used a less effective regimen of tissue plasminogen activator (t-PA) than is currently used. Nevertheless, after 90 minutes of treatment they obtained a flow of grade 3 (according to the Thrombolysis in Myocardial Infarction . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.